Biotech, artificial intelligence, personalized drugs – what will the future of healthcare look like?
The healthcare sector is getting increasingly integrated with science and technology, giving room for unique innovation development. From artificial intelligence to genetic engineering, from health gadgets to regeneration technologies – these are the trends that we learned about at the EBA Healthtech Talk, on September 6, together with health market leaders, experts, and scientists.
Dmytro Shymkiv, Executive Chairman, Board of Directors, Darnitsa Group
Dmytro Shymkiv, Executive Chairman, Board of Directors, Darnitsa Group, opened the discussion with his presentation on key healthcare trends. He noted the rapid growth of biodata – systems that collect information on human health, as well as the development of artificial intelligence to analyze this data. Decides, AI is used in the role of digital medical assistants – digital humans that are trained to provide a full range of primary care. Mr.Shymkiv revealed that Darnitsa is also studying the use of AI, in particular, to understand the behavior of patients and their compliance to treatment, research in silico, and find new ways to use known molecules. Among other promising trends mentioned are medical robotics, telemedicine, personalized drugs, microbiome, biohacking, and genetic engineering.
Miroslav Saban, Head of Government/ Public Affairs, Philips Central and Eastern Europe and Russia
“Healthcare needs a shift from the volume business to the value one,” said Miroslav Saban, Head of Government/ Public Affairs, Philips Central and Eastern Europe and Russia. He also added about the continuous healthcare and reorientation from treatment to prevention. Mr. Saban believes that with its footprint in digital technologies, Ukraine can build an excellent platform to scale public access to health services, particularly in the regions and rural areas. Some progress can be seen now in this direction, but the system still faces a lack of resources and professionals. Therefore, Mr. Saban encourages healthcare stakeholders to cooperate and share experiences. Thus, within the Philips HealthWorks program, innovative healthcare companies have the opportunity to apply for a grant and receive support from Philips.
Alexander Koliada, geneticist, founder, and Scientific Director of Diagen
In turn, Alexander Koliada, geneticist, founder, and research director of the Diagen Molecular Genetics Laboratory, made a warning about the bubble effect in biotechnology. According to his estimates, the technologies of the future will be spread in the world unevenly, and a lot of investment is needed to activate the market. So, it is likely that many ideas will not be implemented, because science is advancing slow. Meanwhile, Alexander does not see further development of medicine without gene therapy as developments in this area can prevent a huge number of diseases. Thus, scientists are trying to find mechanisms to “shut down” or slow down the aging process, which is a key trigger for health problems.
Maxim Ketko, CEO, founder IMESC
“The key question for the medicine now is how to cure. But it will change in the future as the focus will be made on how to prevent and avoid diseases,” commented Maxim Ketko, CEO, founder IMESC “and for this, in fact, technological changes in the field are being implemented.” According to him, the development of connectivity, cloud technologies, artificial intelligence, and cheaper electronics leads to the creation of a multimodal system for collecting medical information with the use of our everyday life gadgets. This system monitors the health of the patient 24 / 7 responding to its changes, and in the near future will detect diseases in the early stages and prevent their progression. Such systems are already working and are being put on the market by Ukrainian companies. to the countries of Western Europe. Thus, IMESC has been creating functional diagnostic technologies for 20 years and successfully exports its products to Western Europe.
After the speeches, the participants of the event had the opportunity to ask questions. So, during the Q&A part, we touched upon such topical issues as patient data security, telemedicine in Ukraine, the situation with the coronavirus, the shortage of intellectual staff, and so on. The full record of the discussion can be viewed at the link:
We thank all participants and speakers for an incredibly interesting and informative conversation!